Coronavirus-induced coagulopathy during the course of disease.
Marie Sophie FriedrichJan-Dirk StudtJulia BraunDonat R SpahnAlexander KasererPublished in: PloS one (2020)
We find coagulation alterations in COVID-19 patients indicating significant hypercoagulability. These alterations are visible despite antithrombotic treatment, and peak around week 3-4 of the disease.